Plain-English translation of NCT06072586 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Phase
Safety & dosing
Sponsor
St. Joseph's Hospital and Medical Center, Phoenix
Collaborators
Ivy Brain Tumor Center, Barrow Neurological Institute
Enrollment target
~82 participants
Started
October 2023
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Phase 0 Navigator
Chief Scientific Officer/Director of the Ivy Brain Tumor Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.